Olympics: Muehlegg in positive drug test
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Johann Muehlegg, a cross-country skier from Spain who has won three gold medals at the Winter Olympics, has tested positive for a performance-enhancing drug similar to the banned blood-boosting agent, erythropoietin (EPO).
A random urine test on Thursday found traces of dar-bepoetin in the German-born skier, who won golds in the 30km freestyle, 50km classical cross-country and combined pursuit. Results from a second test were expected late yesterday.
It was not clear whether Muehlegg will be stripped of his medals or suspended. He was called before the International Olympic Committee's disciplinary panel yesterday, along with Spanish Olympic officials and the team doctor.
Darbepoetin is used to treat anaemia by boosting the production of red blood cells. Since it is relatively new, it is not on the IOC's list of banned substances, though it has similar properties to EPO.
Two other unnamed athletes also tested positive, according to the IOC, though their names were not expected to be released yesterday.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments